FDA Approved: BEPOTASTINE BESILATE — Original Application (Bausch & Lomb Americas Inc.)

View source ↗

Summary

FDA approved the original NDA for bepotastine besilate (Bausch & Lomb Americas Inc.), an ophthalmic antihistamine, for allergic conjunctivitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Conjunctivitis

Drugs mentioned

• Bepotastine besilate (Bepotastine besilate)

Snippet

ORIG AP for BEPOTASTINE BESILATE (BEPOTASTINE BESILATE)